2003
DOI: 10.3892/ijmm.12.2.147
|View full text |Cite
|
Sign up to set email alerts
|

Sesquiterpenes (costunolide and zaluzanin D) isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia HL-60 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
16
0
2

Year Published

2007
2007
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(20 citation statements)
references
References 0 publications
2
16
0
2
Order By: Relevance
“…While the mechanisms of the growth inhibitory effect of costunolide in some cancer cells have previously been demonstrated (6,19,25,27), our study is the first time to describe this in human lung squamous carcinoma cells. In conclusion, costunolide induced apoptosis in SK-MES-1 cells accompany with a marked loss of G1/S phase cells.…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…While the mechanisms of the growth inhibitory effect of costunolide in some cancer cells have previously been demonstrated (6,19,25,27), our study is the first time to describe this in human lung squamous carcinoma cells. In conclusion, costunolide induced apoptosis in SK-MES-1 cells accompany with a marked loss of G1/S phase cells.…”
Section: Discussionmentioning
confidence: 84%
“…Furthermore, costunolide potentiates 1,25-(OH)2D3-induced differentiation in HL-60 promyelocytic leukemia cells by modulating NF-κB activation (16,17). Previous studies have demonstrated that costunolide has anti-tumor potential by inhibiting proliferation, inducing apoptosis and reducing invasion and metastasis in a number of tumor cells including intestinal neoplasia and melanoma, leukemia and hepatocellular carcinoma cells, and cervical, prostate, bladder, colon and breast cancer cells (6,(18)(19)(20)(21)(22)(23)(24)(25). The effects of costunolide on human lung squamous carcinoma cells are still unknown.…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported that some kinds of sesquiterpene compounds induced apoptosis in cancer cells (Furuya et al, 1994;Woynarowski et al, 1997) and costunolide was also proven to have preventive effects on intestinal carcinogenesis, (Mori et al, 1994) suggesting an apoptosis-inducing activity of costunolide. Studies demonstrate that costunolide induces apoptosis in HL-60 human leukemia cells by the ROS-mediated mitochondrial permeability transition and resultant cytochrome c release , activates the cleavage of poly-(ADP-ribose) polymerase (Park et al, 2001a), by depleting intracellular thiols (Choi et al, 2002a) and inducing the chromatin condensation (Hibasami et al, 2003;Komiya et al, 2004). Costunolide -induced apoptotic mechanisms are that the receptormediated pathway precedes the mitochondriadependent pathway, caused by the inhibition of telomerase activity via suppression of hTERT in NALM-6 cells (Kanno et al, 2008), alters the balance of antiapoptotic Bcl-2 (Choi et al, 2002a;Rasul et al, 2011) and induces apoptosis by activation of c-Jun N-terminal kinase (JNK) in leukemic U937 cells (Choi and Lee, 2009) and inhibition of the prosurvival Akt and nuclear factor kappa B signaling pathway in human endometriotic epithelial cells (Kim et al, 2011a).…”
Section: Effects On Apoptosismentioning
confidence: 99%
“…Furthermore, costunolide potentiated 1,25-(OH)2D3-induced differentiation in HL-60 promyelocytic leukemia cells (Choi et al, 2002b;Kim et al, 2008;Kim et al, 2002), via the interference with NF-κB activation. Further studies demonstrate that costunolide has antitumor potential by inhibiting proliferation, inducing apoptosis and reducing invasion and metastasis of a wide variety of tumor cells, including breast cancer cells (Bocca et al, 2004;Choi et al, 2005;Choi et al, 2011), hepatocellular carcinoma cells (Chen et al, 1995;Liu et al, 2011a;Sun et al, 2003), prostate cancer cells (Hsu et al, 2011), leukemia cells (Choi et al, 2002a;Choi and Lee, 2009;Choi et al, 2002b;Hibasami et al, 2003;Kanno et al, 2008;Kim et al, 2008;Kim et al, 2002;Kim et al, 2011b;Komiya et al, 2004;Lee et al, 2001;Song et al, 2001;Srivastava et al, 2006), gastric cancer cells (Ko et al, 2005;Rasul et al, 2011), colon cancer cells (Kawamori et al, 1995;Mori et al, 1994), melanoma cells (Chen et al, 2007;Park et al, 2001b), cervical cancer cells (Sun et al, 2003), KB and P388 tumor cell (Mondranondra et al, 1990), and platinum-resistant human ovarian cancer cells . It was also reported that costunolide inhibited angiogenic response by blocking the angiogenic factor signaling pathway (Jeong et al, 2002) and microtubule-interactting activity of costunolide (Bocca et al, 2004).…”
Section: Biological Functionsmentioning
confidence: 99%
“…It also had cytotoxic properties against MCF-7, NCI-H460, and SF-268 cancer cell lines in vitro (Chang et al, 2010), P-388, L-1210 leukemia and SNU-5 stomach cancer cells and against human A549, SK-OV-3, SK-MEL-2, and HCT15 tumor cells . Costunolide (1) and the guainolide zaluzanin D (147) displayed strong growth inhibitory effect against human promyelotic leukemia HL-60 cells by induction of chromatin condensation in the HL-60 cells (Hibasami et al, 2003).…”
Section: Antitumor and Cytotoxicmentioning
confidence: 99%